Question 1

What is the catalog number for DNALI1 CRISPRa sgRNA lentivector (set of three targets)(Human)?

Accepted Answer

The catalog number for DNALI1 CRISPRa sgRNA lentivector (set of three targets)(Human) is 18426121.

Question 2

What sizes are available for DNALI1 CRISPRa sgRNA lentivector (set of three targets)(Human)?

Accepted Answer

DNALI1 CRISPRa sgRNA lentivector (set of three targets)(Human) is available in the following size(s): 3x 1.0µg DNA.

Question 3

Is DNALI1 CRISPRa sgRNA lentivector (set of three targets)(Human) in stock?

Accepted Answer

DNALI1 CRISPRa sgRNA lentivector (set of three targets)(Human) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What buffer is this product supplied in?

Accepted Answer

The formulation or storage buffer is listed on the product datasheet. If you require a carrier-free or custom formulation, contact us before ordering, as this may involve a made-to-order production timeline.

Question 5

What dilution range is recommended for immunohistochemistry (IHC) with this antibody?

Accepted Answer

A starting IHC dilution range is listed on the datasheet, but should be optimized for your specific tissue type and staining protocol.

Question 6

Can I request a Safety Data Sheet (SDS) for this product?

Accepted Answer

Yes, safety data sheets are available for hazardous or chemically classified products and can be provided on request or downloaded from the product page.

DNALI1 CRISPRa sgRNA lentivector (set of three targets)(Human)

Product Specifications

Gene Name

Gene Aliases

Accession Number

Reactivity

Vector Name

Shipping Conditions

Storage Conditions

Frequently Asked Questions

Explore Other Products

Anti-Kv1.4/KCNA4 Antibody Picoband® (Dylight488 Conjugate)

Osteopontin Rabbit Polyclonal Antibody

CD14 (Monocyte / Macrophage Marker) (LPSR/2397), CF568 conjugate, 0.1mg/mL

Anti-MEKK3/MAP3K3 Antibody Picoband®, APC Conjugate

Cytokeratin 8/18 (C-51), CF568 conjugate, 0.1mg/mL

CD44v4 (Marker of Tumor Metastasis), 0.2mg/mL